The B.S. degree in Bioengineering obtained from the University of California, Riverside will provide individuals with the basic education to enter the fields of bioengineering, biomedical engineering and biotechnology. In general the term "bioengineering" is sometimes associated more with the medical industry and the term "biotechnology" is more associated with the pharmaceutical and food industries. Our degree provides the background for the individual to enter either industry. In addition, the B.S. in Bioengineering from the University of California Riverside also prepares the interested student for graduate education and medical school.
Training bioengineers is particularly important in the State of California. The 2004 Annual Report of the California Healthcare Institute indicated that the biomedical and biotechnology industry is one of the prime employers of technology trained individuals in the State of California. This report goes on to give the following encouraging statistics for opportunities for students with a bioengineering education.
"Today 2,600 biomedical companies in California - 86% of them founded in the last 25 years - and 87 public and private research institutions continue to advance scientific knowledge and develop new treatments for serious diseases such as cancer, and cardiovascular, respiratory, and infectious disease. The pace of progress is accelerating with the expansion of information-based technology approaches - for example, genomics is mining the human genome for biological information to create preventive therapies, and nanotechnology is developing sensor technology and using microchips to diagnose disease. And as the industry matures in California with more products in advanced clinical trials, it is moving beyond a primarily R&D-based industry, adding more manufacturing to its repertoire.
"California continues to receive more funds from the National Institutes of Health (NIH) - in 2003, approximately $2.9 billion - than any other state. And the total reported private investment in research and development is $15.5 billion, with the average company investing 48% of its revenues back into R&D. The industry employs more than 230,000 Californians in jobs with an estimated average annual salary of $67,000, and total estimated wages and salaries paid of $14 billion. It generates $32.3 billion in worldwide revenue and more than $7 billion for the state in exports. California companies are addressing issues of global health in new ways?developing medicines for diseases in developing countries, and new pricing strategies to balance the industry?s successes with responsibilities to the developing world. They are balancing business risks by building networks of alliances that enable them to integrate virtually, with each member of a network focused on a specific role in bringing high value products to market. In many ways, it is an exciting time for what has always been a vibrant, innovative, and resilient industry."